Literature DB >> 14562544

[Interventional MR-mammography: manipulator-assisted large core biopsy and interstitial laser therapy of tumors of the female breast]].

Stefan O Pfleiderer1, Jürgen R Reichenbach, Susanne Wurdinger, Christiane Marx, Martin G Freesmeyer, Jörg Vagner, Harald Fischer, Achim Schneider, Werner A Kaiser.   

Abstract

The present study investigated the clinical application of magnetic resonance (MR)-guided breast interventions, such as manipulator-assisted large core breast biopsy (LCBB) inside a 1.5 T whole-body magnet and MR-guided interstitial laser therapy (ILT). Sixteen patients underwent LCBB and 1 additional patient underwent 4 sessions of ILT of a recurrent undifferentiated lymph node metastasis in the axilla using a Nd-YAG laser (1064 nm). Temperature changes of the tumor tissue during ILT were monitored using phase images of a gradient echo sequence (GRE) (TR/TE/FA = 25/12/30). In 5 patients the biopsy findings were histopathologically confirmed after open surgery. In 3 patients, the biopsy missed one tubular and one ductal carcinoma; one invasive carcinoma was underestimated. Eight patients with benign findings are still in the follow-up period. The heating zone during ILT was well delineated on subtracted phase images. No severe adverse events were observed with LCBB or ILT. MR-guided breast biopsies are feasible with the manipulator system inside a whole-body 1.5 Tesla MR scanner. GRE information is suitable for therapy monitoring during ILT within the tumor. Further studies are necessary to evaluate the accuracy of the manipulator system and the efficacy of ILT in the treatment of breast lesions.

Entities:  

Mesh:

Year:  2003        PMID: 14562544     DOI: 10.1078/0939-3889-00164

Source DB:  PubMed          Journal:  Z Med Phys        ISSN: 0939-3889            Impact factor:   4.820


  1 in total

1.  Robot-assisted biopsy using ultrasound guidance: initial results from in vitro tests.

Authors:  Joachim Kettenbach; Gernot Kronreif; Michael Figl; Martin Fürst; Wolfgang Birkfellner; Rudolf Hanel; Helmar Bergmann
Journal:  Eur Radiol       Date:  2004-09-24       Impact factor: 5.315

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.